Literature DB >> 26605322

Ultrasound attacks Alzheimer's disease?

Shuko Takeda1, Ryuichi Morishita1.   

Abstract

Entities:  

Year:  2015        PMID： 26605322      PMCID： PMC4630553          DOI： 10.3978/j.issn.2305-5839.2015.09.21

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  17 in total

1.  Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound.

Authors:  M Shimamura; N Sato; Y Taniyama; S Yamamoto; M Endoh; H Kurinami; M Aoki; T Ogihara; Y Kaneda; R Morishita
Journal:  Gene Ther       Date:  2004-10       Impact factor: 5.250

Review 2.  The therapeutics of Alzheimer's disease: where we stand and where we are heading.

Authors:  Dennis J Selkoe
Journal:  Ann Neurol       Date:  2013-09       Impact factor: 10.422

3.  Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.

Authors:  C Sturchler-Pierrat; D Abramowski; M Duke; K H Wiederhold; C Mistl; S Rothacher; B Ledermann; K Bürki; P Frey; P A Paganetti; C Waridel; M E Calhoun; M Jucker; A Probst; M Staufenbiel; B Sommer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 4.  The secretases: enzymes with therapeutic potential in Alzheimer disease.

Authors:  Bart De Strooper; Robert Vassar; Todd Golde
Journal:  Nat Rev Neurol       Date:  2010-02       Impact factor: 42.937

5.  Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer's disease mouse model.

Authors:  Gerhard Leinenga; Jürgen Götz
Journal:  Sci Transl Med       Date:  2015-03-11       Impact factor: 17.956

Review 6.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

7.  Brain interstitial oligomeric amyloid β increases with age and is resistant to clearance from brain in a mouse model of Alzheimer's disease.

Authors:  Shuko Takeda; Tadafumi Hashimoto; Allyson D Roe; Yukiko Hori; Tara L Spires-Jones; Bradley T Hyman
Journal:  FASEB J       Date:  2013-05-02       Impact factor: 5.191

8.  Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center.

Authors:  Alberto Serrano-Pozo; Jing Qian; Sarah E Monsell; Matthew P Frosch; Rebecca A Betensky; Bradley T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2013-12       Impact factor: 3.685

Review 9.  Neuroinflammation in Alzheimer's disease.

Authors:  Michael T Heneka; Monica J Carson; Joseph El Khoury; Gary E Landreth; Frederic Brosseron; Douglas L Feinstein; Andreas H Jacobs; Tony Wyss-Coray; Javier Vitorica; Richard M Ransohoff; Karl Herrup; Sally A Frautschy; Bente Finsen; Guy C Brown; Alexei Verkhratsky; Koji Yamanaka; Jari Koistinaho; Eicke Latz; Annett Halle; Gabor C Petzold; Terrence Town; Dave Morgan; Mari L Shinohara; V Hugh Perry; Clive Holmes; Nicolas G Bazan; David J Brooks; Stéphane Hunot; Bertrand Joseph; Nikolaus Deigendesch; Olga Garaschuk; Erik Boddeke; Charles A Dinarello; John C Breitner; Greg M Cole; Douglas T Golenbock; Markus P Kummer
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

10.  Passive immunization against pyroglutamate-3 amyloid-β reduces plaque burden in Alzheimer-like transgenic mice: a pilot study.

Authors:  Jeffrey L Frost; Bin Liu; Martin Kleinschmidt; Stephan Schilling; Hans-Ulrich Demuth; Cynthia A Lemere
Journal:  Neurodegener Dis       Date:  2012-02-16       Impact factor: 2.977
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.